OVERVIEW

Optimizing Patient Outcomes using Drug-Eluting Stent Technology is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Dec 20, 2018 - Dec 31, 2019.

Accreditation:
Physicians
NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 credit.
PAs should only claim credit commensurate with the extent of their participation.

Nurses
This continuing nursing education activity awards 1.0 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.
Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

AHRA
Optimizing Patient Outcomes using Drug-Eluting Stent Technology is approved for 1 ARRT Category A CE credit by The Association for Medical Imaging Management, AHRA.
AHRA is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

Intended Learners:
This activity is designed for interventional cardiologists, vascular surgeons, interventional radiologists, cardiothoracic surgeons, clinical cardiologists, nurses, technicians and others involved in the treatment of complex coronary lesions.

Learning Objectives:
After completing this activity, participants should be able to:
• Identify various patient subsets and best treatment options based on the lesion type, disease and patient presentation.
• Understand recent and ongoing clinical trials for drug-eluting stent technology.
• Compare and contrast the indications for various drug-eluting stents.